Delivery Order SPE2DB24D2101-SPE2DB25FKNAE
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $12,279.00 to supply Privigen 10% Vial 200ML, a pharmaceutical product, with completion targeted for August 20, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and serves as a major pharmaceutical...
- The Defense Logistics Agency awarded a $7,367.40 delivery order to AmerisourceBergen Drug Corp for PRIVIGEN 10% Vial 200ML, a pharmaceutical product used in federal medical supply chains. This contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026. The delivery order carries a firm fixed price structure with an ultimate completion date of August 22, 2025, and...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Privigen 10% vial, a 200 mL intravenous immunoglobulin product, with a ceiling value of $6,139.50 and a period of performance through May 21, 2025. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,911.60 Firm Fixed Price Delivery Order is for the supply of PRIVIGEN 10% VIAL 200ML medical products, with a period of performance through May 5, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- The Department of Defense Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $1,793.37 for INFUVITE Adult Vial 10ML, a parenteral nutrition product used in clinical settings. This firm fixed-price delivery order, issued on August 1, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was...
- The Defense Logistics Agency awarded a delivery order valued at $7,325.64 to AmerisourceBergen Drug Corp for GAMUNEX-C, a 10 gram/100 mL immunoglobulin vial product, with an ultimate completion date of August 21, 2025. This competitive award, issued on July 31, 2025, utilizes a firm fixed price contract type with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is a...
- The Defense Logistics Agency awarded a delivery order valued at $9,522.72 to AmerisourceBergen Drug Corp for GAMUNEX-C 20 gram/200 milliliter vials. This is a firm fixed price contract with an ultimate completion date of August 18, 2025, and was competitively awarded without a set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order is issued under AmerisourceBergen's larger Indefinite...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $11,994.94 by the Defense Logistics Agency's Medical Supply Chain on July 28, 2025. This firm fixed price delivery order, which is effective through July 29, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through...
- The Defense Logistics Agency awarded a $40,532.76 firm fixed-price delivery order to AmerisourceBergen Drug Corp for GAMUNEX-C 20 gram/200 milliliter vials, with an ultimate completion date of August 22, 2025. This competitively awarded, non-set-aside contract represents a child delivery order under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical distributor,...
- The U.S. Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $10,223.24 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This competitively awarded, firm fixed-price delivery order was issued on July 28, 2025, with an ultimate completion date of the same day, indicating a short-duration transaction. The award carries no set-aside designation and represents performance at the contractor's corporate...
- SPE2DB24D2101Indefinite Delivery Contract
- SPE2DB24D2101-SPE2DB25FKNAEDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $12,279.00 to AmerisourceBergen Drug Corp for the supply of Privigen 10% Vial 200ML, a pharmaceutical product for delivery to Conshohocken, PA. This competitive award, issued on August 4, 2025, with an ultimate completion date of August 25, 2025, operates under a firm fixed-price contract structure with no set-aside designation. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a substantial $999,999,999.00 ceiling value through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, maintains an extensive portfolio of federal medical supply contracts primarily with the Defense Logistics Agency. The company's contract awards consistently demonstrate capability in delivering diverse pharmaceutical products including specialty medications, vaccines, and medical supplies across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This specific delivery order for Privigen reflects the company's ongoing role as a critical vendor within the DLA's pharmaceutical supply chain for federal military and veteran healthcare procurement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.3k | 8/4/25 |